echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The Upstream and Downstream products of Acenocoumarol-d4

    The Upstream and Downstream products of Acenocoumarol-d4

    • Last Update: 2023-05-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Acenocoumarol-d4 is an anti-coagulant drug that is used to prevent blood clots from forming.
    It is commonly used in patients who have artificial heart valves, atrial fibrillation, or other conditions that increase the risk of blood clots.
    The drug works by inhibiting the action of vitamin K-dependent coagulation factors, which are proteins that play a crucial role in blood clotting.


    In the chemical industry, Acenocoumarol-d4 is used as an intermediate in the production of other chemicals and drugs.
    The upstream products of Acenocoumarol-d4 are the raw materials that are used to manufacture the drug, while the downstream products are the final products that are derived from the drug.


    One of the upstream products of Acenocoumarol-d4 is coumarin, which is a naturally-occurring compound that is found in various plants, including the tonka bean.
    Coumarin is used as a precursor in the synthesis of Acenocoumarol-d4, and it is converted into the drug through a series of chemical reactions.


    Another upstream product of Acenocoumarol-d4 is 4-hydroxycoumarin, which is also used in the synthesis of the drug.
    4-hydroxycoumarin is synthesized by hydroxylating coumarin, and it is then converted into Acenocoumarol-d4 through a series of chemical reactions.


    In addition to coumarin and 4-hydroxycoumarin, Acenocoumarol-d4 is also derived from other upstream products, such as benzene, nitrogen, and hydrochloric acid.
    These raw materials are used in the production of the drug through a series of chemical reactions that involve the addition of functional groups, the formation of ring structures, and the condensation of various chemicals.


    Once Acenocoumarol-d4 has been synthesized, it is used as a raw material in the production of downstream products.
    One of the most common downstream products of Acenocoumarol-d4 is warfarin, which is another anti-coagulant drug that is commonly used to prevent blood clots.
    Warfarin is synthesized by adding an electrophilic group to Acenocoumarol-d4, which results in the formation of a new compound that has a different chemical structure but similar anti-coagulant properties.


    Another downstream product of Acenocoumarol-d4 is the anticoagulant rodenticide difenacoum, which is used to control rodent populations in agricultural and urban settings.
    Difenacoum is synthesized by adding a second electrophilic group to Acenocoumarol-d4, which results in the formation of a new compound that has a different chemical structure but similar anticoagulant properties.


    In addition to warfarin and difenacoum, Acenocoumarol-d4 is also used as a raw material in the production of other downstream products, such as a variety of drugs, pesticides, and other chemicals.
    The drug is also used in research and development, where it is studied for its potential therapeutic effects on various diseases, including cancer, Alzheimer's disease, and others.


    In conclusion, Acenocoumarol-d4 is an important intermediate in the production of various chemicals and drugs.
    The upstream products of the drug include coumarin, 4-hydroxycoumarin, benzene, nitrogen, and hydrochloric acid, among others.
    These raw materials are used in the production of the drug through a series of chemical reactions that involve the addition of functional groups, the formation of ring structures, and the condensation of various chemicals.


    The downstream products of Acenocoumarol-d4 include warfarin, difenacoum, and other anticoagulant drugs, as well as a variety of other chemicals and drugs.
    These products are used in a variety of applications, including the treatment of blood clots, the control of rodent populations, and the development of new drugs


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.